Share
864 Posts.
lightbulb Created with Sketch. 33
clock Created with Sketch.
24/04/18
13:46
Share
Originally posted by bruutz82
↑
Thank you for your concern.
And that is why you need to be able to derisk the company when study results are impending.
If you check out the NTI threads I have done a lot of research and presented it derisking NTI.
In regards to NUH - someone wrote NUH has been hitting its milestones. And that is nice but as I have noted continually; NUH is not being priced on development based milestones anymore. Receipts are what will control NUHs price and I have seen little in regards to projection of sales or expectations from the company. This means NUH's receipts, outflows and balance become even more important.
If NUH pull out a big 4C then great. But stop falling for NUH's continual development stage milestone deflections like the one today. They are mere distractions to what matters to NUH right now.
Expand
what do you think matters to NUH right now?